Bernard, B.F.

kidney marrow bone marrow radioactivity lu-dota study tumor patient norharman peptide treatment uptake radiation damage therapy imaging blood amifostine group control somatostatin effect receptor analogue result synthase jong m animal binding withdrawal toxicity lysine value radiolabeled radionuclide creatinine krenning ep bakker wh control rats activity level protein bone marrow aspirate radiolabelled somatostatin analogues alcohol ethanol organ concentration liver tumour score 185 mbq radiolabelled injection serum retention 125 i-ast binding tissue platelet krenning 555 mbq 278 mbq atp synthase count ratio alcohol withdrawal octreotate interval bone marrow dosimetry dosimetry kooij pp administration tumours netherland valkema r cycle radiolabeled peptides i-ast correlation serum creatinine